VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BOLD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BOLDBoundless Bio, Inc.
$2.50$56M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBOLDQuarterly Financials

Boundless Bio, Inc. (BOLD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Boundless Bio, Inc. (BOLD) quarterly income statement — complete revenue, gross profit & net income history

BOLD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q4'22Q3'19Q2'19Q1'19Q4'18Q3'18Q2'18Q1'18
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold284K307K310K317K000265K000000000000
COGS % of Revenue--------------------
Gross Profit-284K-307K-310K-317K000-265K000000000000
Gross Margin %--------------------
Gross Profit Growth %----19.62%----------------
Operating Expenses14.19M13.7M14.84M16.74M17.34M18.28M18.71M19.13M16.88M13.8M14.95M13.96M12.07M47.83M47.08M51.83M37.6M37.73M32.63M26.41M
OpEx % of Revenue--------------------
Selling, General & Admin4.74M4.19M4.47M4.84M5.2M4.96M4.63M4.66M3.75M3.38M3.31M2.88M2.42M10.19M9.78M11.99M9.38M7.82M6.28M6.52M
SG&A % of Revenue--------------------
Research & Development9.73M10.44M10.36M11.9M12.14M13.31M14.09M14.47M13.13M10.41M11.64M11.07M9.66M37.64M37.3M39.84M28.21M29.92M26.35M19.89M
R&D % of Revenue--------------------
Other Operating Expenses-284K-934K000000000000000000
Operating Income-14.47M-14M-15.15M-17.06M-17.34M-18.28M-18.71M-19.39M-16.88M-13.8M-14.95M-13.96M-12.07M-146.73M-98.91M-51.83M-134.37M-96.77M-59.04M-26.41M
Operating Margin %--------------------
Operating Income Growth %16.53%23.39%19.06%12.02%-2.71%-32.49%-25.16%-38.9%--14.27%----51.62%-67.53%-96.25%-44.21%-45.97%-43.7%-44.75%
EBITDA-14.19M-13.7M-14.84M-16.74M-17.02M-17.98M-18.45M-19.13M-16.62M-13.55M-14.72M-13.72M-11.83M-141.14M-96.24M-49.55M-130.86M-95.58M-57.55M-25.14M
EBITDA Margin %--------------------
EBITDA Growth %16.64%23.84%19.59%12.45%-2.43%-32.72%-25.38%-39.38%--14.49%----47.66%-67.22%-97.1%-42.22%-46.43%-42.88%-43.76%
D&A (Non-Cash Add-back)284K307K310K317K317K296K262K265K263K247K235K238K239K5.6M2.67M2.28M3.51M1.19M1.49M1.27M
EBIT-14.47M-14M-13.88M-15.68M-17.34M-18.28M-18.71M-19.39M-16.88M-13.8M-14.95M-13.96M-12.07M0000000
Net Interest Income920K1.12M1.27M1.39M1.58M1.92M2.17M2.38M1.42M1.62M1.71M1.55M297K0000000
Interest Income920K1.12M1.27M1.39M1.58M1.92M2.17M2.38M1.42M1.62M1.71M1.55M297K0000000
Interest Expense00000000000000000000
Other Income/Expense920K1.12M1.27M1.39M1.58M1.83M2.21M2.42M1.45M1.65M1.78M1.56M294K6.84M4.75M2.44M5.55M3.54M2.1M839K
Pretax Income-13.55M-12.88M-13.88M-15.68M-15.76M-16.45M-16.51M-16.98M-15.43M-12.14M-13.17M-12.4M-11.78M-139.9M-94.16M-49.39M-128.82M-93.23M-56.94M-25.57M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-13.55M-12.88M-13.88M-15.68M-15.76M-16.45M-16.51M-16.98M-15.43M-12.14M-13.17M-12.4M-11.78M-139.9M-94.16M-49.39M-128.82M-93.23M-56.94M-25.57M
Net Margin %--------------------
Net Income Growth %13.98%21.66%15.93%7.66%-2.13%-35.44%-25.32%-36.93%--3.1%----50.06%-65.36%-93.15%-42.76%-41.55%-39.37%-41.16%
Net Income (Continuing)-13.55M-12.88M-13.88M-15.68M-15.76M-16.45M-16.51M-16.98M-15.43M-12.14M-13.17M-12.4M-11.78M-139.9M-94.16M-49.39M-128.82M-93.23M-56.94M-25.57M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.60-0.58-0.62-0.70-0.71-0.84-0.74-0.77-0.69-0.55-0.59-0.56-0.53-3.14-2.14-1.12-2.93-2.12-1.29-0.58
EPS Growth %15.49%30.95%16.22%9.09%-2.9%-52.73%-25.42%-37.5%--3.77%----48.11%-65.89%-93.1%13.82%18.15%24.12%30.12%
EPS (Basic)-0.60-0.58-0.62-0.70-0.71-0.84-0.74-0.77-0.69-0.55-0.59-0.56-0.53-3.14-2.14-1.12-2.93-2.12-1.29-0.58
Diluted Shares Outstanding22.41M22.36M22.39M22.36M22.3M16.98M22.25M22.02M22.24M22.24M22.24M22.24M22.24M44.54M44.03M44.03M44.03M44.03M44.03M44.03M
Basic Shares Outstanding22.41M22.36M22.39M22.36M22.3M16.98M22.25M22.02M22.24M22.24M22.24M22.24M22.24M44.54M44.03M44.03M44.03M44.03M44.03M44.03M
Dividend Payout Ratio--------------------